We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for afamelanotide (Clinuvel Pharmaceuticals Ltd)
Active ingredients
afamelanotide
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
For the prevention of phototoxicity in adult patients with erythropoietic protoporphyria
Therapeutic area
Haematology